Cell counts and viability are determined using a Nexcelom Cellometer® with acridine orange and propidium iodide to identify live and dead nucleated cells, respectively, per the recommendations provided by Nexcelom. Given the cellular debris that can be present, we do not recommend the use of trypan blue-based cell counting methods, as this will overestimate the number of dead cells.
White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Xenium In Situ Services are Now Available
Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy
White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Xenium In Situ Services are Now Available
Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy